The controversies in the diagnosis of polycystic ovary syndrome;Kontrowersje w rozpoznawaniu zespołu policystycznych jajników

Polski Merkuriusz Lekarski

Volumn 33, Issue 193, 2012, Pages 32-37

  Katulski, Krzysztof ^a   Czyzyk, Adam ^a   Mȩczekalski, Błazej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Diagnosis; Polycystic ovary syndrome

Indexed keywords

ADULT; FEMALE; HUMAN; OVARY POLYCYSTIC DISEASE; PRACTICE GUIDELINE; REVIEW;

ADULT; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PRACTICE GUIDELINES AS TOPIC;

EID: 84865271219     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Amer S. A., Li T. C., Bygrave C., Sprigg A. et al.: An evaluation of the interobserverand intra-observer variability of the ultrasound diagnosis of polycystic ovaries. Hum. Reprod., 2002;17(6);1616-1622. (Pubitemid 34661817)
2. Archer J. S., Chang R. J.: Hirsutism and acne in polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol., 2004;18(5);737-754. (Pubitemid 40424608)
3. Asuncion M., Calvo R. M., San Millan J. L et al.: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab., 2000;85;2434-2438. (Pubitemid 32269197)
4. Azziz R., Carmina E., Dewailly D. et al.: Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril., 2009;91(2);456-488.
5. Azziz R., Sanchez L. A., Knochenhauer E. S. et al.: Androgen excess in women: experience with over 1000 consecutive patients. J. Clin. Endocrinol. Metab., 2004;89;453-462. (Pubitemid 38269843)
6. Azziz R., Waggoner W. T., Ochoa T., Knochenhauer E. S., Boots L. R.: Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril, 1998;70;274-278. (Pubitemid 28361480)
7. Azziz R., Woods K. S., Reyna R. et al.: The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab., 2004;89;2745-2749. (Pubitemid 38766360)
8. Balen A. H., Laven J. S., Tan S. L., Dewailly D.: Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum. Reprod. Update, 2003;9(6);505-514. (Pubitemid 38072143)
9. Barth J. H., Yasmin E., Balen A. H.: The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin. Endocrinol. (Oxf), 2007;67(6);811-815. (Pubitemid 350135121)
10. Burke B. M., Cunliffe W. J.: The assessment of acne vulgaris - the Leeds technique. Br. J. Dermatol., 1984;111;83-92. (Pubitemid 14086231)
11. Burkhart C. N., Gottwald L.: Assessment of etiologic agents in acne pathogenesis. Skinmed, 2003;2(4);222-228.
12. Chang W. Y., Knochenhauer E. S., Bartolucci A. A. et al.: Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril, 2005;83;1717-1723. (Pubitemid 40824804)
13. Chiazze L. Jr., Brayer F. T., Macisco J. J. Jr et al.: The length and variability of the human menstrual cycle. JAMA, 1968;203;377-380.
14. Cresswell J., Fraser R., Bruce C. et al.: Relationship between polycystic ovaries, body mass index and insulin resistance. Acta Obstet. Gynecol. Scand., 2003;82(1);61-64. (Pubitemid 36228409)
15. De Ugarte CM., Woods K. S., Bartolucci A. A. et al.: Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J. Clin. Endocrinol. Metab., 2006;91(4);1345-1350.
16. Diamanti-Kandarakis E., Panidis D.: Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin. Endocrinol., 2007;67;735-742. (Pubitemid 47620439)
17. Ecochard R., Marret H., Rabilloud M. et al.: Sensitivity and specificity of ultrasound indices of ovulation in spontaneous cycles. Eur. J. Obstet. Gynecol. Reprod. Biol., 2000;91(1);59-64. (Pubitemid 30246020)
18. Ehrmann D. A., Rosenfield R. L., Barnes R. B. et al.: Detection of functional ovarian hyperandrogenism in women with androgen excess. N. Engl. J. Med., 1992;327;157-162.
19. Escobar-Morreale H. F., Asuncion M., Calvo R. M. et al.: Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur. J. Endocrinol., 2001;145(5);619-624. (Pubitemid 33069338)
20. Espinos J. J., Calaf J., Estadella J. et al.: Hirsutism scoring in polycystic ovary syndrome: concordance between clinicians' and patients' self-scoring. Fertil Steril, 2010;94(7);2815-2816.
21. Ferriman D., Gallwey J. D.: Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 1961;21;1440-1447.
22. Gibson J. R., Harvey S. G., Barth J. et al.: Assessing inflammatory acne vulgaris-correlation between clinical and photographic methods. Br. J. Dermatol., 1984;111; supl. 27;168-170. (Pubitemid 14053618)
23. Glueck C. J., Papanna R., Wang P. et al.: Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metab. Clin. Exp., 2003;52;908-915. (Pubitemid 36957780)
24. Goulden V., Stables G. I., Cunliffe W. J.: Prevalence of facial acne in adults. J. Am. Acad. Dermatol., 1999;41(4);577-580. (Pubitemid 29480407)
25. Guyatt G., Weaver B., Cronin L. et al.: Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J. Clin. Epidemiol., 2004;57;1279-1287. (Pubitemid 40023148)
26. Hahn S., Tan S., Elsenbruch S. et al.: Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine - Westphalia. Horm. Metab. Res., 2005;37;438-444. (Pubitemid 41081225)
27. Hanson A. E.: Hippocrates: diseases of women 1. Signs (Chic), 1975;1;567-584.
28. Jonard S., Robert Y., Cortet-Rudelli C. et al.: Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum. Reprod., 2003;18(3);598-603. (Pubitemid 36329332)
29. Knochenhauer E. S., Key T. J., Kahsar-Miller M. et al.: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J. Clin. Endocrinol. Metab., 1998;83;3078-3082. (Pubitemid 28500937)
30. Komindr S., Kurtz B. R., Stevens M. D. et al.: Relative sensitivity and responsivity of serum Cortisol and two adrenal androgens to alpha- adrenocorticotropin-(1-24) in normal and obese, nonhirsute, eumenorriieic women. J. Clin. Endocrinol. Metab., 1986;63(4);860-864. (Pubitemid 16004287)
31. Kumar A., Woods K. S., Bartolucci A. A. et al.: Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin. Endocrinol. (Oxf), 2005;62;644-649. (Pubitemid 40825931)
32. Lam P. M., Johnson I. R., Raine-Fenning N. J.: Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum. Reprod., 2007;22(12);3116-3123. (Pubitemid 351696762)
33. Legrain S., Massien C., Lahlou N. et al.: Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J. Clin. Endocrinol. Metab., 2000;85;3208-3217.
34. Longcope C.: Dehydroepiandrosterone metabolism. J. Endocrinol., 1996;150 (supl.); S125-7.
35. Malcolm C. E., Cumming D. C.: Does anovulation exist in eumenorriieic women? Obstet. Gynecol. 2003;102(2);317-318. (Pubitemid 36937004)
36. Miller K. K., Rosner W., Lee H. et al.: Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J. Clin. Endocrinol. Metab., 2004;89;525-833.
37. Ogunmakin K. O., Rashid R. M.: Alopecia: the case for medical necessity. Skinmed., 2011;9(2);79-84.
38. Petsos P., Mamtora H., Ratcliffe W. A. et al.: Inadequate luteal phase usually indicates ovulatory dysfunction: observations from serial hormone and ultrasound monitoring of 115 cycles. Gynecol. Endocrinol., 1987;1(1);37-45.
39. Pugeat M., Crave J. C., Tourniaire J. et al.: Clinical utility of sex hormone - binding globulin measurement. Horm. Res., 1996;45;148-155. (Pubitemid 26079699)
40. Rosenfield R. L.: Clinical practice. Hirsutism. N. Engl. J. Med., 2005;353(24);2578-2588.
41. Rosner W., Auchus R. J., Azziz R. et al.: Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J. Clin. Endocrinol. Metab., 2007;92(2);405-413.
42. Speroff L., Fritz M. A.: Clinical Gynecologic Endocrinology and Infertility. Lippincott, Williams & Wilkins, 2005, 403ff.
43. Steck T., Wernze H.: Is determination of the "free androgen index" for hormone screening in polycystic ovaries of value? Gynakol. Geburtshilfliche Rundsch, 1993;33(3);173-179.
44. Stein I. F., Leventhal M. L.: Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol., 1935;29;181-191.
45. Teede H., Deeks A., Moran L.: Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health BMC. Med., 2010;30;8;41.
46. The Rotterdam ESHRE/ASRM - sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod., 2004;19;41-47.
47. Van Uytfanghe K., Stockl D., Kaufman J. M. et al.: Evaluation of a candidate reference measurement procedure for serum free testosterone based on ultrafiltration and isotope dilution - gas chromatography - mass spectrometry. Clin. Chem., 2004;50;2101-2110. (Pubitemid 39425848)
48. Vexiau P., Chaspoux C., Boudou P. et al.: Role of androgens in femalepattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism. Arch. Dermatol. Res., 2000;292;598-604. (Pubitemid 32112967)
49. Williamson K., Gunn A. J., Johnson N. et al.: The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust. N Z J Obstet. Gynaecol., 2001;41(2);202-206. (Pubitemid 32515023)
50. Yildiz B. O., Woods K. S., Stanczyk F. et al.: Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 2004;89(11);5558-5562. (Pubitemid 39518440)
51. Zawadski J. K., Dunaif A.: Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Polycystic ovary syndrome. Dunaif A., Givens J. R., Haseltine F. P., Merriam G. R. (ed.). Boston, MA: Blackwell Scientific Publications, 1992;377-384.